Turgeon, Ricky D.
Zieroth, Shelley
Bewick, David
Chow, Chi-Ming
Clarke, Brian
Cowan, Simone
Fordyce, Christopher B.
Fournier, Anne
Gin, Kenneth
Gupta, Anil
Hardiman, Sean
Jackson, Simon
Lau, Benny
Leong-Poi, Howard
Mansour, Samer
Marelli, Ariane
Quraishi, Ata Rehman
Roifman, Idan
Ruel, Marc
Sapp, John
Singh, Gurmeet
Small, Gary
Virani, Sean
Wood, David A.
Krahn, Andrew
Funding for this research was provided by:
Novartis
Servier Laboratories
Boehringer Ingelheim
Novartis
Edwards Lifesciences
SV
Novartis
Servier
This article is maintained by: Elsevier
Article Title: Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence
Journal Title: Canadian Journal of Cardiology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cjca.2020.05.033
Content Type: simple-article
Copyright: © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.